Journal article

Valproic acid influences the expression of genes implicated with hyperglycaemia-induced complement and coagulation pathways

MB Felisbino, M Ziemann, I Khurana, J Okabe, K Al-Hasani, S Maxwell, KN Harikrishnan, CBM de Oliveira, MLS Mello, A El-Osta

Scientific Reports | Published : 2021

Open access

Abstract

Because the liver plays a major role in metabolic homeostasis and secretion of clotting factors and inflammatory innate immune proteins, there is interest in understanding the mechanisms of hepatic cell activation under hyperglycaemia and whether this can be attenuated pharmacologically. We have previously shown that hyperglycaemia stimulates major changes in chromatin organization and metabolism in hepatocytes, and that the histone deacetylase inhibitor valproic acid (VPA) is able to reverse some of these metabolic changes. In this study, we have used RNA-sequencing (RNA-seq) to investigate how VPA influences gene expression in hepatocytes. Interesting, we observed that VPA attenuates hyper..

View full abstract

University of Melbourne Researchers

Grants

Awarded by National Health and Medical Research Council


Funding Acknowledgements

This work was supported by the Sao Paulo Research Foundation (FAPESP, Grant Nos. 2010/50015-6, 2012/032385, 2014/10198-5, and 2015/10356-2), the Brazilian National Council for Research and Development (CNPq, Grant No. 304668/2014-1) and the NSFC (81561128017) and NHMRC (1113188) International Joint Program. Professor Sam El-Osta is a National Health and Medical Research Council (NHMRC) Senior Research Fellow (1154650, 0526681).